The patients undergoing elective VATS video-
Conditions
Interventions
Group 1 (ITM group,
n=19) receives a single shot of 0.2 mg ITM prior to administration of general anesthesia.,Group 2 (control group,
n=19) receives only general anesthesia as usual (standard treatment).
ITM group,Control Group
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients undergoing elective VATS 2. aged over 18 years 3. ASA physical status I to III.
Exclusion criteria
Exclusion criteria: 1. unwillingness and/or inability to provide written informed consent to participate in the study, 2. pregnancy 3. contraindication to spinal block, 4. history of allergy to opioid 5. Receiving opioid therapy for chronic pain 6. History of severe postoperative nausea and vomiting (PONV), 7. History of previous surgical intervention at spinal T12-L5 level or significant spinal deformity, 8. Learning difficulty or communication problems, and 9. Retaining endotracheal tube after the operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain 1st, 6th, 12th, 24th, 48th hours post-operation 11â€point numeric pain rating scales (NRS) that runs from 0-10 | — |
Secondary
| Measure | Time frame |
|---|---|
| Dose of morphine given as intravenous patient-controlled analgesia (IVPCA), 1st, 6th, 12th, 24th, 48th hours post-operation Dose of morphine in milligram ,Incidence of common side effects 3-point ordinal scale (0 = no symptom, 1 = having symptom without treatment, and 2 = having symptom report of post operative Nausea/vomiting, and pruritus PONV and pruritus,patient sedation 1st, 6th, 12th, 24th, 48th hours post-operation 5-point sedation Ramsay's score | — |
Contacts
Public ContactAmorn Vijitpavan
Faculty of Medicine, Ramathibodi Hospital
Outcome results
None listed